Mirum Pharmaceuticals (MIRM) Inventory (2021 - 2026)

Mirum Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $25.5 million for Q1 2026.

• On a quarterly basis, Inventory rose 13.83% year-over-year to $25.5 million in Q1 2026; TTM through Mar 2026 was $25.5 million, a 13.83% increase from a year earlier, with the FY2025 full-year figure at $24.9 million, up 11.09% from the prior year.
• Inventory climbed to $25.5 million in Q1 2026 per MIRM's latest filing, from $24.9 million in the prior quarter.
• Across five years, Inventory topped out at $25.5 million in Q1 2026 and bottomed at $1.6 million in Q1 2022.
• The 5-year median for Inventory is $21.6 million (2024), against an average of $16.7 million.
• Across the five-year window, Inventory surged 318.54% in 2023 and retreated 2.95% in 2024, its largest moves.
• Year by year, Inventory stood at $5.6 million in 2022, then soared by 300.93% to $22.3 million in 2023, then rose by 0.41% to $22.4 million in 2024, then grew by 11.09% to $24.9 million in 2025, then increased by 2.54% to $25.5 million in 2026.
• Per Business Quant, the three latest MIRM Inventory figures stand at $25.5 million (Q1 2026), $24.9 million (Q4 2025), and $24.0 million (Q3 2025).